Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price objective upped by Morgan Stanley from $70.00 to $75.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical research company’s stock. Morgan Stanley’s price target would indicate a potential downside of 1.26% from the stock’s previous […]
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price objective upped by Morgan Stanley from $70.00 to $75.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical research company’s stock. Morgan Stanley’s price target would indicate a potential downside of 1.26% from the stock’s previous […]
